Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-01

FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved a supplemental application for PROCHLORPERAZINE EDISYLATE (ANDA212257) filed by Somerset Therapeutics, LLC. This approval relates to the generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

SUPPL AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)